| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. (KPTI) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. KPTI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 198.3K | $1.78M | - | |
| VP | 79.5K | $715.6K | - | |
| VP | 67.4K | $606.5K | - | |
| VP | 65.1K | $585.7K | - | |
| VP | 56.3K | $506.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 10, 2019 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 20,000 | $16.51 | $330,106.00 | -1.6% | |
| Dec 10, 2019 | Shacham Sharon79 | President &CSO | Sale+OE | 20,000 | $16.51 | $330,106.00 | -1.6% | |
| Dec 9, 2019 | Mirza Mansoor Raza79 | Director | Sale+OE | 10,342 | $17.02 | $176,034.18 | -65.9% | |
| Dec 6, 2019 | Primiano Christopher Brett | EVP, Cbo, GC &Secretary | Sale+OE | 13,000 | $17.45 | $226,908.00 | -37.2% | |
| Nov 11, 2019 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 20,000 | $14.69 | $293,864.00 | -1.6% | |
| Nov 11, 2019 | Shacham Sharon79 | President &CSO | Sale+OE | 20,000 | $14.69 | $293,864.00 | -1.6% | |
| Nov 1, 2019 | Shacham Sharon79 | President &CSO | Sale+OE | 20,000 | $12.00 | $240,000.00 | -1.6% | |
| Nov 1, 2019 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 20,000 | $12.00 | $240,000.00 | -1.6% | |
| Sep 16, 2019 | Kauffman Michael78 | Chief Executive Officer | Sale+OE | 20,000 | $12.00 | $240,000.00 | -1.6% | |
| Sep 16, 2019 | Shacham Sharon79 | President &CSO | Sale+OE | 20,000 | $12.00 | $240,000.00 | -1.6% |